Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: a randomized clinical trial. Kelsen SG, Agache IO, Soong W, Israel E, et al. J Allergy Clin Immunol 2021 Apr 16. pii: S0091-6749(21)00609.

Read + Share

Amedeo Smart

Independent Medical Education

Kelsen SG, Agache IO, Soong W, Israel E, et al. Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: a randomized clinical trial. J Allergy Clin Immunol 2021 Apr 16. pii: S0091-6749(21)00609.
PMID: 33872652